AMSTERDAM (Reuters) -Biotechnology firm Galapagos said on Tuesday it would wind down its cell therapy business after attempts to sell it were unsuccessful, affecting 365 jobs in Europe, China and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback